NCT00219843View on ClinicalTrials.gov

Intralesional PV-10 Chemoablation of Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

August 31, 2007

Conditions
Melanoma
Interventions
DRUG

PV-10 (rose bengal disodium, 10%)

Trial Locations (2)

2060

Sydney Melanoma Unit, North Sydney

2298

Newcastle Melanoma Unit, Waratah

Sponsors
All Listed Sponsors
lead

Provectus Pharmaceuticals

INDUSTRY